Filing Details
- Accession Number:
- 0000950170-23-065868
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-22 16:05:11
- Reporting Period:
- 2023-11-20
- Accepted Time:
- 2023-11-22 16:05:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1745999 | Beam Therapeutics Inc. | BEAM | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1963878 | Christine Bellon | C/O Beam Therapeutics Inc., 238 Main Street Cambridge MA 02142 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-20 | 4,182 | $7.22 | 86,584 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-11-20 | 5,818 | $7.22 | 92,402 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-11-20 | 5,000 | $30.00 | 87,402 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-20 | 5,000 | $31.00 | 82,402 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-11-20 | 4,182 | $0.00 | 4,182 | $7.22 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-11-20 | 5,818 | $0.00 | 5,818 | $7.22 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,492 | 2029-05-16 | No | 4 | M | Direct | |
10,918 | 2029-05-17 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.
- The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
- The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.